CoChat

Polyethylene glycol loxenatide injections added to metformin effectively improve glycemic control and exhibit favorable safety in type 2 diabetic patients: 聚乙二醇洛塞那肽注射液注射联合盐酸二甲双胍有效安全地改善2型糖尿病患者的血糖控制

Chen, Xiaoping, Lv, Xiaofeng, Yang, Gangyi, Lu, Dan, Piao, Chunli, Zhang, Xiaomei, Jiang, Hong, Xie, Ying, Yang, Jinkui, Li, Xuefeng, Li, Yanbing, Xiao, Xinhua, Li, Yukun, Sun, Li, Zheng, Shaoxiong, Cheng, Qingfeng, Peng, Yongde, Yang, Wenying · 2017 · Journal of Diabetes
Cited by 33

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Background: The aim of the present study was to evaluate the efficacy and safety of polyethylene glycol loxenatide (PEX168) injections in Chinese type 2 diabetic (T2D) patients. Methods: The present multicenter randomized double‐blind parallel placebo‐controlled clinical trial enrolled patients who had been treated with a stable dose of metformin (≥1500 mg/day) for ≥12 weeks and had an HbA1c level between 7% and 11%. Subjects were randomly divided into three groups (1: 1: 1) and were treated with once weekly subcutaneous injections of either placebo or 100 or 200 μg PEX168 for 12 weeks. All subjects continued to receive metformin daily. Results: After 12 weeks treatment, the adjusted least‐squares mean of HbA1c reductions from baseline values in the 100 and 200 μg PEX168 groups were significantly higher than in the placebo group (−1.02% [95% confidence interval {CI} –1.33, −0.71), −1.36% [95% CI –1.68, −1.04], and 0.13% [95% CI –0.20, 0.45], respectively; P < 0.05). After treatment, 50% and 60.5% of subjects in the 100 and 200 μg PEX168 groups, respectively, achieved HbA1c levels <7% (P < 0.01 for both vs placebo [HbA1c 11.1%]). The most frequent adverse reactions in the PEX168 groups were mild to moderate dose‐dependent gastrointestinal reactions. There were no reports of hypoglycemia or pancreatitis in any of the groups. Conclusions: Continuous 12 week treatment with PEX168 showed excellent safety and efficacy in T2D patients whose glucose was not well controlled with metformin alone.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/1753-0407.12397

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

Metadata

Authors
Chen, X., Lv, X., Yang, G., Lu, D., Piao, C., Zhang, X., Jiang, H., Xie, Y., Yang, J., Li, X., Li, Y., Xiao, X., Li, Y., Sun, L., Zheng, S., Cheng, Q., Peng, Y., & Yang, W.
Venue
Journal of Diabetes
Publisher
Wiley
Published
2016-06-21
Volume
9
Issue
2
Pages
158-167
ISSN
  • 1753-0393 (ISSN-L)
  • 1753-0407
OpenAlex
W2301888354
Cited by
33
References
8
FWCI
1.44
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.